speb/financial-data huggingface dataset:
Financial ratios for JBS — quarterly report dated 2025-09-30
Total revenue: 26584687058.82353
Gross profit: 3496996470.5882354
Operating income: 1436648235.2941177
Net income: 757792941.1764706
Capital expenditures: 582133573.8588235
Operating cash flow: 1245863909.1294117
Depreciation & amortization: 1004557693.4588237
Net tangible assets: 1141443529.4117646
Owner earnings: 1180217060.776471
Return on net tangible assets (%): 103.39688564222602
Capex to operating income (%): 40.5202581646332
Buffett classification: The Good
Stock price: 13.82
P/E ratio: 5.143524412119494
Shares outstanding: 776086920
Book value: 11187243529.411766
P/B ratio: 0.9587277872518036
Market cap (USD): 10725521234.4
Debt to equity: 2.3477442847983263
Current ratio: 1.6016600026320187
Quick ratio: 0.8412858245487592
Effective tax rate (%): 20.999434592397538
Interest coverage ratio: 2.542989110855201
COGS to revenue (%): 86.84582420379641
SG&A to revenue (%): 7.464438617118107
Free cash flow (dilution-adjusted): 632662077.4470588
Buyback yield (%): 0
Retained earnings: 1965448235.2941177
Inventory turnover: 2.3391842330137544
Receivables turnover: 5.001637701622229
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6834073065722595
FCF margin (%): 2.3797988520503446
Revenue growth (%): 1.07845136781423
Rule of 40 score: 3.4582502198645746
Financial ratios for JBS — annual report dated 2025-12-31
Total revenue: 101393155294.11765
Gross profit: 13293270588.235294
Operating income: 5061040000
Net income: 2623284705.882353
Capital expenditures: 2383610588.2352943
Operating cash flow: 3449356470.5882354
Depreciation & amortization: 2715905882.352941
Net tangible assets: 1206368235.2941177
Owner earnings: 2955580000
Return on net tangible assets (%): 244.99816171630354
Capex to operating income (%): 47.09724855435433
Buffett classification: The Good
Stock price: 13.35
P/E ratio: 3.9495371427917942
Shares outstanding: 776086920
Book value: 11203283529.411766
P/B ratio: 0.9247967664836915
Market cap (USD): 10360760382
Debt to equity: 2.4003312684275016
Current ratio: 1.5975139947720507
Quick ratio: 0.9101061272018861
Effective tax rate (%): 14.903114073284796
Interest coverage ratio: 2.563762956976847
COGS to revenue (%): 86.88938069865303
SG&A to revenue (%): 7.8216267110361395
Free cash flow (dilution-adjusted): 937303529.4117646
Buyback yield (%): 6.813036176066026
Retained earnings: 2453849411.764706
Inventory turnover: 9.438562296546314
Receivables turnover: 16.60389588872192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.797636365735016
FCF margin (%): 0.924424855595891
Revenue growth (%): 26.113263769791022
Rule of 40 score: 27.037688625386913
Financial ratios for JBS — quarterly report dated 2025-12-31
Total revenue: 27132977647.058823
Gross profit: 3376190588.2352943
Operating income: 1118370588.235294
Net income: 511787058.8235294
Capital expenditures: 967034117.6470588
Operating cash flow: 2277165882.352941
Depreciation & amortization: 733721176.4705882
Net tangible assets: 1206368235.2941177
Owner earnings: 278474117.64705884
Return on net tangible assets (%): 23.083674577950543
Capex to operating income (%): 86.46812852732178
Buffett classification: The Gruesome
Stock price: 13.35
P/E ratio: 3.989458088636594
Shares outstanding: 776086920
Book value: 11203283529.411766
P/B ratio: 0.9247967664836915
Market cap (USD): 10360760382
Debt to equity: 2.4003312684275016
Current ratio: 1.5975139947720507
Quick ratio: 0.9101061272018861
Effective tax rate (%): -16.20493916202535
Interest coverage ratio: 2.348595089917704
COGS to revenue (%): 87.55687402926354
SG&A to revenue (%): 8.00252143788039
Free cash flow (dilution-adjusted): 1277551764.7058823
Buyback yield (%): 2.697246956923659
Retained earnings: 2453849411.764706
Inventory turnover: 2.5451782981223303
Receivables turnover: 4.44323026239741
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.82797608996737
FCF margin (%): 4.70848345995806
Revenue growth (%): 2.0624301012913944
Rule of 40 score: 6.770913561249454
Financial ratios for KAYNES.NS — annual report dated 2023-03-31
Total revenue: 137163702.80146164
Gross profit: 37715347.137637034
Operating income: 18406942.752740562
Net income: 11595127.892813643
Capital expenditures: 7079415.347137637
Operating cash flow: -5067235.079171742
Depreciation & amortization: 2282704.0194884287
Net tangible assets: 111622898.90377589
Owner earnings: 6798416.565164436
Return on net tangible assets (%): 6.090521418033576
Capex to operating income (%): 38.46057133025853
Buffett classification: The Good
Stock price: 11.727161997563947
P/E ratio: 67.79797982184125
Shares outstanding: 67034654
Book value: 116973081.60779539
P/B ratio: 6.720573965422987
Market cap (USD): 786126246.908648
Debt to equity: 0.16113100549904252
Current ratio: 2.9675841155652694
Quick ratio: 1.9708529645203232
Effective tax rate (%): 24.470997072334754
Interest coverage ratio: 4.562418863025693
COGS to revenue (%): 72.50340551667061
R&D to revenue (%): 0.05541179667422659
SG&A to revenue (%): 1.9468721639194613
Free cash flow (dilution-adjusted): -12146650.426309379
Buyback yield (%): 0
Retained earnings: 27537271.61997564
Inventory turnover: 1.9761426455354292
Receivables turnover: 4.959412681775342
Capitalized R&D asset: 179910.97787007707
ROCI (R&D-adjusted, %): 15.035329297515748
FCF margin (%): -8.855586556956045
Rule of 40 score: -8.855586556956045
Financial ratios for KAYNES.NS — annual report dated 2024-03-31
Total revenue: 216407123.15625376
Gross profit: 54649478.35471879
Operating income: 27777551.265139706
Net income: 21979733.7810289
Capital expenditures: 45880681.136826955
Operating cash flow: 10517927.809089819
Depreciation & amortization: 3014869.8884758363
Net tangible assets: 290784266.69864494
Owner earnings: -20886077.46732222
Return on net tangible assets (%): -7.182671093057301
Capex to operating income (%): 165.1717989785742
Buffett classification: The Gruesome
Stock price: 34.45237523992322
P/E ratio: 105.07420502425708
Shares outstanding: 67034654
Book value: 298413238.9974817
P/B ratio: 7.739278128025379
Market cap (USD): 2309503053.68642
Debt to equity: 0.12961629404115302
Current ratio: 3.5134367525233383
Quick ratio: 2.768661024385142
Effective tax rate (%): 20.849077380823857
Interest coverage ratio: 4.505154037653649
COGS to revenue (%): 74.74691333738589
R&D to revenue (%): 0.046103914455073336
SG&A to revenue (%): 1.4307729221514347
Free cash flow (dilution-adjusted): -35362753.32773714
Buyback yield (%): 0
Retained earnings: 49058400.28780429
Inventory turnover: 2.4600364018354113
Receivables turnover: 5.075241933442641
Capitalized R&D asset: 201873.0534281816
ROCI (R&D-adjusted, %): 9.149856141956821
Rosenberg metric: 222.8032328401301
FCF margin (%): -16.340845352952616
Revenue growth (%): 57.772879221183935
Rule of 40 score: 41.432033868231315
Financial ratios for KAYNES.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 301749880.55422837
Buffett classification: The Gruesome
Stock price: 64.8082895365504
Shares outstanding: 67034654
Book value: 310684065.93406594
P/B ratio: 13.983341090741536
Market cap (USD): 4344401265.414476
Debt to equity: 0.2684818844103932
Current ratio: 2.414032332835809
Quick ratio: 1.7772376764447637
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KAYNES.NS — quarterly report dated 2024-12-31
Total revenue: 77069005.71162139
Gross profit: 23758713.13672922
Operating income: 9696118.428721296
Net income: 7747056.766522904
Capital expenditures: 0
Depreciation & amortization: 1264016.785173097
Owner earnings: 9011073.551696
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 86.45879473132067
P/E ratio: 187.030234989242
Shares outstanding: 67034654
Market cap (USD): 5795735390.071104
Effective tax rate (%): 17.79388482089848
Interest coverage ratio: 3.083707136237257
COGS to revenue (%): 69.17215563201876
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KAYNES.NS — annual report dated 2025-03-31
Total revenue: 318184708.9081131
Gross profit: 96100303.95136778
Operating income: 42782207.15454758
Net income: 34303600.65466448
Capital expenditures: 110912672.43394902
Operating cash flow: -9623100.303951368
Depreciation & amortization: 5230301.613280336
Net tangible assets: 304202829.0858078
Owner earnings: -71378770.16600421
Return on net tangible assets (%): -23.464203268757274
Capex to operating income (%): 259.2495334176779
Buffett classification: The Gruesome
Stock price: 55.40144707667173
P/E ratio: 108.26317835469
Shares outstanding: 67034654
Book value: 332503156.41805
P/B ratio: 11.16926791279746
Market cap (USD): 3713816835.884001
Debt to equity: 0.3174765630933061
Current ratio: 1.5951640527884305
Quick ratio: 1.110996836712916
Effective tax rate (%): 21.04035261447054
Interest coverage ratio: 3.612697190467729
COGS to revenue (%): 69.79732172512412
R&D to revenue (%): 0.031707517804708145
SG&A to revenue (%): 1.7654437288922724
Free cash flow (dilution-adjusted): -120535772.73790039
Buyback yield (%): 0
Retained earnings: 82310965.63011456
Inventory turnover: 2.3325839275167817
Receivables turnover: 4.73694176615963
Capitalized R&D asset: 192817.42483048205
ROCI (R&D-adjusted, %): 12.36282941005097
Rosenberg metric: 415.45484933949035
FCF margin (%): -37.88232726567299
Revenue growth (%): 47.03060798898578
Rule of 40 score: 9.148280723312787
Financial ratios for KAYNES.NS — quarterly report dated 2025-03-31
Total revenue: 115090367.07972877
Gross profit: 36922258.59247135
Operating income: 17643558.56909048
Net income: 13584521.861117605
Capital expenditures: 0
Depreciation & amortization: 1979892.4479775543
Net tangible assets: 304202829.0858078
Owner earnings: 15564414.30909516
Return on net tangible assets (%): 5.1164594214555565
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 55.40144707667173
P/E ratio: 68.34647685528594
Shares outstanding: 67034654
Book value: 332503156.41805
P/B ratio: 11.16926791279746
Market cap (USD): 3713816835.884001
Debt to equity: 0.3174765630933061
Current ratio: 1.5951640527884305
Quick ratio: 1.110996836712916
Effective tax rate (%): 18.128399515260828
Interest coverage ratio: 5.123154214331783
COGS to revenue (%): 67.91889753301987
Buyback yield (%): 0
Retained earnings: 82310965.63011456
Inventory turnover: 0.8210107032831834
Receivables turnover: 1.7133958717672038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.1002904255542045
Revenue growth (%): 49.33417917752384
Rule of 40 score: 49.33417917752384
Financial ratios for KAYNES.NS — quarterly report dated 2025-06-30
Total revenue: 78804820.96887434
Gross profit: 32514392.698338408
Operating income: 11399134.097823543
Net income: 8730634.214837352
Capital expenditures: 0
Depreciation & amortization: 1827989.7027849287
Owner earnings: 10558623.917622281
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 71.31991575005851
P/E ratio: 159.03373117160925
Shares outstanding: 67034654
Market cap (USD): 4780905875.614323
Effective tax rate (%): 22.349537398399367
Interest coverage ratio: 3.4270386266094417
COGS to revenue (%): 58.74060457395027
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -31.52787416666909
Rule of 40 score: -31.52787416666909
Financial ratios for KAYNES.NS — quarterly report dated 2025-12-31
Total revenue: 89565779.21354572
Gross profit: 30918681.07385541
Operating income: 11018268.909435224
Net income: 8537596.07886822
Capital expenditures: 0
Depreciation & amortization: 2272585.496268241
Owner earnings: 10810181.57513646
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 44.703130221677625
P/E ratio: 77.63403371330993
Shares outstanding: 67034654
Market cap (USD): 2996658867.127103
Effective tax rate (%): 34.109373522357004
Interest coverage ratio: 3.978400772262891
COGS to revenue (%): 65.47935903048636
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 13.655202958866772
Rule of 40 score: 13.655202958866772
Financial ratios for KPN.AS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.534090909090909
Shares outstanding: 3773262403
Market cap (USD): 9561789953.056818
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KPN.AS — annual report dated 2022-12-31
Total revenue: 5650000000
Gross profit: 4063829787.2340426
Operating income: 1273404255.319149
Net income: 809574468.0851064
Capital expenditures: 1022340425.531915
Operating cash flow: 2327659574.4680853
Depreciation & amortization: 1431914893.6170213
Net tangible assets: 815957446.8085107
Owner earnings: 1219148936.1702125
Return on net tangible assets (%): 149.4132985658409
Capex to operating income (%): 80.28404344193818
Buffett classification: The Gruesome
Stock price: 2.617021276595745
P/E ratio: 12.197405402601841
Shares outstanding: 3773262403
Book value: 3885106382.9787235
P/B ratio: 2.5416827796768895
Market cap (USD): 9874707990.829788
Debt to equity: 1.722343921139102
Current ratio: 0.8275862068965517
Quick ratio: 0.7984542211652794
Effective tax rate (%): 22.860020140986908
Interest coverage ratio: 5.593457943925234
COGS to revenue (%): 28.073809075503675
Free cash flow (dilution-adjusted): 1037234042.5531915
Buyback yield (%): 3.231983532744386
Retained earnings: -5697872340.425532
Inventory turnover: 30.428571428571427
Receivables turnover: 21.677551020408163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.64283629997082
FCF margin (%): 18.358124646959144
Rule of 40 score: 18.358124646959144
Financial ratios for KPN.AS — annual report dated 2023-12-31
Total revenue: 6043333333.333333
Gross profit: 4396666666.666667
Operating income: 1464444444.4444444
Net income: 937777777.7777778
Capital expenditures: 1025555555.5555556
Operating cash flow: 2491111111.111111
Depreciation & amortization: 1340000000
Net tangible assets: 832222222.2222222
Owner earnings: 1252222222.222222
Return on net tangible assets (%): 150.46728971962614
Capex to operating income (%): 70.03034901365706
Buffett classification: The Good
Stock price: 3.0888888888888886
P/E ratio: 12.42851834163507
Shares outstanding: 3773262403
Book value: 3956666666.666668
P/B ratio: 2.945708924554899
Market cap (USD): 11655188311.488888
Debt to equity: 1.9064869418702606
Current ratio: 0.75453209211171
Quick ratio: 0.7334639882410584
Effective tax rate (%): 22.518382352941178
Interest coverage ratio: 4.954887218045113
COGS to revenue (%): 27.247655819084386
Free cash flow (dilution-adjusted): 1097777777.7777777
Buyback yield (%): 2.8599566512774066
Retained earnings: -5722222222.222222
Inventory turnover: 34.46511627906977
Receivables turnover: 22.475206611570247
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.906384645515079
FCF margin (%): 18.165103879389594
Revenue growth (%): 6.961651917404124
Rule of 40 score: 25.126755796793717
Financial ratios for KPN.AS — annual report dated 2024-12-31
Total revenue: 5836458333.333334
Gross profit: 4259375000
Operating income: 1463541666.6666667
Net income: 883333333.3333334
Capital expenditures: 980208333.3333334
Operating cash flow: 2358333333.3333335
Depreciation & amortization: 1291666666.6666667
Net tangible assets: 579166666.6666667
Owner earnings: 1194791666.6666665
Return on net tangible assets (%): 206.29496402877692
Capex to operating income (%): 66.97508896797153
Buffett classification: The Good
Stock price: 3.4270833333333335
P/E ratio: 14.639190219186322
Shares outstanding: 3773262403
Book value: 3681250000
P/B ratio: 3.5127428709309565
Market cap (USD): 12931284693.614584
Debt to equity: 2.008205998868138
Current ratio: 0.5990547459629775
Quick ratio: 0.5813312327688065
Effective tax rate (%): 21.93548387096774
Interest coverage ratio: 5.053956834532373
COGS to revenue (%): 27.0212386221667
SG&A to revenue (%): 2.1774049616276994
Free cash flow (dilution-adjusted): 987500000
Buyback yield (%): 1.6110799372950741
Retained earnings: -5213541666.666667
Inventory turnover: 33.644444444444446
Receivables turnover: 22.68421052631579
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.03876898481215
FCF margin (%): 16.919507406746384
Revenue growth (%): -3.423193601765015
Rule of 40 score: 13.49631380498137
Financial ratios for KPN.AS — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.9782608695652173
Shares outstanding: 3773262403
Market cap (USD): 15011022168.456522
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KPN.AS — quarterly report dated 2025-06-30
Total revenue: 1712941176.4705882
Gross profit: 1167058823.5294118
Operating income: 408235294.11764705
Net income: 247058823.52941176
Capital expenditures: 0
Depreciation & amortization: 383529411.7647059
Net tangible assets: 280000000
Owner earnings: 630588235.2941177
Return on net tangible assets (%): 225.21008403361344
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.670588235294118
P/E ratio: 17.83315683322619
Shares outstanding: 3773262403
Book value: 4047058823.5294113
P/B ratio: 4.354608063927326
Market cap (USD): 17623354988.129414
Debt to equity: 2.0337209302325583
Current ratio: 0.7239418825015793
Quick ratio: 0.6967782691092862
Effective tax rate (%): 23.357664233576646
Interest coverage ratio: 5.257575757575758
COGS to revenue (%): 31.868131868131872
Buyback yield (%): 0
Retained earnings: -5836470588.235294
Inventory turnover: 10.790697674418604
Receivables turnover: 2.394736842105263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.203175482322533
Rule of 40 score: 0
Financial ratios for KPN.AS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.694117647058824
Shares outstanding: 3773262403
Market cap (USD): 17712137632.905884
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KPN.AS — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.576470588235295
P/E ratio: 69.89519403652382
Shares outstanding: 3773262403
Market cap (USD): 17268224409.023533
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KPN.AS — annual report dated 2025-12-31
Total revenue: 6820000000
Gross profit: 4935294117.6470585
Operating income: 1688235294.1176472
Net income: 1005882352.9411765
Capital expenditures: 1125882352.9411764
Operating cash flow: 2715294117.647059
Depreciation & amortization: 1583529411.764706
Net tangible assets: 518823529.41176474
Owner earnings: 1463529411.7647061
Return on net tangible assets (%): 282.08616780045355
Capex to operating income (%): 66.68989547038326
Buffett classification: The Good
Stock price: 4.576470588235295
P/E ratio: 17.16724064054971
Shares outstanding: 3773262403
Book value: 4189411764.705883
P/B ratio: 4.121873279323223
Market cap (USD): 17268224409.023533
Debt to equity: 1.961246840775063
Current ratio: 0.636020744931636
Quick ratio: 0.6166902404526167
Effective tax rate (%): 20.261437908496735
Interest coverage ratio: 5.354477611940299
COGS to revenue (%): 27.634983612213215
SG&A to revenue (%): 2.0700362256339484
Free cash flow (dilution-adjusted): 1222352941.1764705
Buyback yield (%): 1.7032303964334168
Retained earnings: -5672941176.470589
Inventory turnover: 39.07317073170732
Receivables turnover: 25.764444444444443
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.569739952718676
FCF margin (%): 17.923063653613937
Revenue growth (%): 16.851686596466166
Rule of 40 score: 34.7747502500801
Financial ratios for LPM.AX — annual report dated 2023-06-30
Operating income: -1343352.9801324503
Net income: -1226054.9668874172
Capital expenditures: 56856.291390728475
Depreciation & amortization: 74885.43046357617
Net tangible assets: 10804221.19205298
Owner earnings: -1208025.8278145695
Return on net tangible assets (%): -11.181054204102466
Buffett classification: The Gruesome
Stock price: 0.17880794701986755
Shares outstanding: 154340000
Book value: 10804221.19205298
P/B ratio: 2.554299662371354
Market cap (USD): 27597218.54304636
Debt to equity: 0.004858169856839128
Current ratio: 8.010590514404404
Quick ratio: 8.010590514404404
Interest coverage ratio: -449.47108353645024
Free cash flow (dilution-adjusted): -3411566.8874172186
Buyback yield (%): 0.2763571527987752
Retained earnings: -1550428.476821192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.426761330276443
Rule of 40 score: 0
Financial ratios for LPM.AX — annual report dated 2024-06-30
Operating income: -1613192
Net income: -1391476.6666666667
Capital expenditures: 23353.333333333332
Depreciation & amortization: 114476.66666666667
Net tangible assets: 14678190.666666666
Owner earnings: -1300353.3333333333
Return on net tangible assets (%): -8.859084630140154
Buffett classification: The Gruesome
Stock price: 0.10666666666666667
Shares outstanding: 154340000
Book value: 14678190.666666666
P/B ratio: 1.1215914622719623
Market cap (USD): 16462933.333333334
Debt to equity: 0.007519773327193916
Current ratio: 11.860261905724723
Quick ratio: 11.860261905724723
Interest coverage ratio: -223.78507352261167
Free cash flow (dilution-adjusted): -6036340.666666667
Buyback yield (%): 1.7047063301801217
Retained earnings: -2952241.3333333335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.94452219605609
Rule of 40 score: 0
Financial ratios for LVE.AX — annual report dated 2021-06-30
Capital expenditures: 269.17293233082705
Buffett classification: The Gruesome
Stock price: 0.06015037593984962
Shares outstanding: 40534169
Market cap (USD): 2438145.5037593986
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LVE.AX — annual report dated 2022-06-30
Total revenue: 2491493.7931034486
Gross profit: 2491493.7931034486
Operating income: 142623.4482758621
Net income: 141347.58620689655
Capital expenditures: 3745.5172413793102
Depreciation & amortization: 41757.93103448276
Net tangible assets: 384650.3448275862
Owner earnings: 179360
Return on net tangible assets (%): 46.629361551825845
Capex to operating income (%): 2.6261581013906885
Buffett classification: The Great
Stock price: 0.034482758620689655
P/E ratio: 9.88860158864916
Shares outstanding: 40534169
Book value: 384650.3448275863
P/B ratio: 3.6337676133990016
Market cap (USD): 1397729.9655172413
Debt to equity: 0.11566976187957533
Current ratio: 1.443732660878717
Quick ratio: 1.443732660878717
Effective tax rate (%): 0
Interest coverage ratio: 21.39499275812125
COGS to revenue (%): 0
R&D to revenue (%): 0.265787094627624
SG&A to revenue (%): 82.0637999748662
Free cash flow (dilution-adjusted): 97777.24137931035
Buyback yield (%): 0
Retained earnings: -11545913.103448275
Receivables turnover: 1224.6325423728815
Capitalized R&D asset: 6622.068965517242
ROCI (R&D-adjusted, %): 37.5794857332546
FCF margin (%): 3.9244425031264996
Rule of 40 score: 3.9244425031264996
Financial ratios for LVE.AX — annual report dated 2023-06-30
Total revenue: 2641623.841059603
Gross profit: 2641623.841059603
Operating income: 124349.00662251655
Net income: 134648.34437086093
Capital expenditures: 1870.1986754966888
Depreciation & amortization: 109972.18543046358
Net tangible assets: 497175.4966887417
Owner earnings: 242750.33112582783
Return on net tangible assets (%): 48.82588396704563
Capex to operating income (%): 1.5039916492248373
Buffett classification: The Great
Stock price: 0.0728476821192053
P/E ratio: 21.929866810283347
Shares outstanding: 40534169
Book value: 532682.7814569536
P/B ratio: 5.5432996167096205
Market cap (USD): 2952820.2582781455
Debt to equity: 0
Current ratio: 1.5540955777776548
Quick ratio: 1.5540955777776548
Effective tax rate (%): 0
Interest coverage ratio: 26.071507914468203
COGS to revenue (%): 0
R&D to revenue (%): 4.239139481735597
SG&A to revenue (%): 76.06331345459796
Free cash flow (dilution-adjusted): 523197.3509933775
Buyback yield (%): 0
Retained earnings: -10182398.013245033
Receivables turnover: 470.7165447250413
Capitalized R&D asset: 116418.90541219457
ROCI (R&D-adjusted, %): 30.31013608362111
Rosenberg metric: 22.67116949973168
FCF margin (%): 19.805899040626223
Revenue growth (%): 6.025704273144088
Rule of 40 score: 25.83160331377031
Financial ratios for LVE.AX — annual report dated 2024-06-30
Total revenue: 3132340.6666666665
Gross profit: 3132340.6666666665
Operating income: 355860.6666666667
Net income: 407368
Capital expenditures: 0
Depreciation & amortization: 2130.6666666666665
Net tangible assets: 905016
Owner earnings: 409498.6666666667
Return on net tangible assets (%): 45.24767149604722
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.06666666666666667
P/E ratio: 6.633505659092843
Shares outstanding: 40534169
Book value: 940146.0000000001
P/B ratio: 2.874317322344969
Market cap (USD): 2702277.933333333
Debt to equity: 0
Current ratio: 2.10903539890866
Quick ratio: 2.10903539890866
Effective tax rate (%): 0.5115647498998687
COGS to revenue (%): 0
R&D to revenue (%): 6.213521688041169
SG&A to revenue (%): 75.97513339864481
Free cash flow (dilution-adjusted): 305064.6666666667
Buyback yield (%): 0
Retained earnings: -9842912.666666666
Receivables turnover: 120.64478110155348
Capitalized R&D asset: 271841.969292837
ROCI (R&D-adjusted, %): 36.652088169946175
Rosenberg metric: 4.382099830665173
FCF margin (%): 9.73919184184096
Revenue growth (%): 18.57633240507961
Rule of 40 score: 28.31552424692057
Financial ratios for MAP.AX — annual report dated 2022-06-30
Total revenue: 3233548.275862069
Gross profit: 1631527.5862068967
Operating income: -11222113.103448275
Net income: -7910640.689655173
Capital expenditures: 1122283.448275862
Depreciation & amortization: 1064042.7586206896
Net tangible assets: 22539496.55172414
Owner earnings: -7968881.379310345
Return on net tangible assets (%): -35.35518799642742
Buffett classification: The Gruesome
Stock price: 0.1310344827586207
Shares outstanding: 700307489
Book value: 23128416.551724136
P/B ratio: 3.967605364936354
Market cap (USD): 91764429.59310345
Debt to equity: 0.0395134166049324
Current ratio: 6.8035960718112625
Quick ratio: 6.7352060847832735
Interest coverage ratio: -1958.8376068376067
COGS to revenue (%): 49.54373811623614
R&D to revenue (%): 114.826842296655
SG&A to revenue (%): 194.37711748276956
Free cash flow (dilution-adjusted): -8497638.620689655
Buyback yield (%): 1.4316681036333199
Retained earnings: -21518953.79310345
Inventory turnover: 6.451991900742431
Receivables turnover: 1.3699402019215092
Capitalized R&D asset: 3712981.379310345
ROCI (R&D-adjusted, %): -32.02850448854345
FCF margin (%): -262.79609567369675
Rule of 40 score: -262.79609567369675
Financial ratios for MAP.AX — annual report dated 2023-06-30
Total revenue: 3589494.0397350993
Gross profit: 1773684.1059602648
Operating income: -13397433.112582782
Net income: -8397491.390728477
Capital expenditures: 364544.37086092716
Depreciation & amortization: 1087305.298013245
Net tangible assets: 23660096.68874172
Owner earnings: -7674730.463576159
Return on net tangible assets (%): -32.437443365259185
Buffett classification: The Gruesome
Stock price: 0.18543046357615894
Shares outstanding: 700307489
Book value: 25545586.75496689
P/B ratio: 5.083396344610373
Market cap (USD): 129858342.33112583
Debt to equity: 0.029444621478662374
Current ratio: 5.30710161362491
Quick ratio: 5.224740757573104
Interest coverage ratio: -1232.867572673533
COGS to revenue (%): 50.586793394114096
R&D to revenue (%): 172.26713499439867
SG&A to revenue (%): 156.86086105588495
Free cash flow (dilution-adjusted): -10219018.543046357
Buyback yield (%): 0.3037573848201007
Retained earnings: -29061387.417218544
Inventory turnover: 4.2547456888057145
Receivables turnover: 0.749030706724524
Capitalized R&D asset: 8671216.067184288
ROCI (R&D-adjusted, %): -30.397548684678483
Rosenberg metric: 0.03828635407263273
FCF margin (%): -284.6924505215367
Revenue growth (%): 11.007900099408126
Rule of 40 score: -273.6845504221286
Financial ratios for MAP.AX — annual report dated 2024-06-30
Total revenue: 8060036.666666667
Gross profit: 3936951.3333333335
Operating income: -17895274
Net income: -13292323.333333334
Capital expenditures: 991551.3333333334
Depreciation & amortization: 1913516
Net tangible assets: 12890736
Owner earnings: -12370358.666666668
Return on net tangible assets (%): -95.96316817493329
Buffett classification: The Gruesome
Stock price: 0.10666666666666667
Shares outstanding: 700307489
Book value: 27477334.666666664
P/B ratio: 2.7185848409071802
Market cap (USD): 74699465.49333334
Debt to equity: 0.038368520071403345
Current ratio: 2.6077589054459005
Quick ratio: 2.4263423676379987
Interest coverage ratio: -1443.2448518737565
COGS to revenue (%): 51.15467216650379
R&D to revenue (%): 89.62872377338233
SG&A to revenue (%): 107.23741951546127
Free cash flow (dilution-adjusted): -13297326
Buyback yield (%): 1.1221356509012002
Retained earnings: -42547453.333333336
Inventory turnover: 2.756613596248819
Receivables turnover: 1.4920979641162562
Capitalized R&D asset: 12592349.279013474
ROCI (R&D-adjusted, %): -38.051917331381865
Rosenberg metric: 0.3498440592218744
FCF margin (%): -164.97848024678134
Revenue growth (%): 124.54520267880118
Rule of 40 score: -40.43327756798017
Financial ratios for MFM — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.52
Shares outstanding: 41187631
Market cap (USD): 227355723.11999997
Buyback yield (%): 50.03172932662968
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFM — annual report dated 2022-10-31
Total revenue: -67909404
Net income: -68261108
Capital expenditures: 0
Operating cash flow: 10847091
Net tangible assets: 224500045
Owner earnings: -68261108
Return on net tangible assets (%): -30.405832658073635
Buffett classification: The Gruesome
Stock price: 3.99
Shares outstanding: 41187631
Book value: 224500045
P/B ratio: 0.732020555675167
Market cap (USD): 164338647.69
Debt to equity: 0
Free cash flow (dilution-adjusted): 10847091
Buyback yield (%): 0
Retained earnings: -55838876
Receivables turnover: -11.35025116683311
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFM — annual report dated 2023-10-31
Total revenue: 1301073
Net income: 1162457
Capital expenditures: 0
Operating cash flow: 8874931
Net tangible assets: 216786567
Owner earnings: 1162457
Return on net tangible assets (%): 0.5362218776221499
Buffett classification: The Gruesome
Stock price: 3.87
P/E ratio: 137.12002419874457
Shares outstanding: 41187631
Book value: 216786567
P/B ratio: 0.7352675683544544
Market cap (USD): 159396131.97
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 28.611538322599884
Free cash flow (dilution-adjusted): 8874931
Buyback yield (%): 0
Retained earnings: -63466802
Receivables turnover: 0.22743836608774817
Capitalized R&D asset: 0
FCF margin (%): 682.1239853567017
Rule of 40 score: 682.1239853567017
Financial ratios for MFM — annual report dated 2024-10-31
Total revenue: 4017896.02
Net income: 46723867
Capital expenditures: 0
Operating cash flow: 9949774
Net tangible assets: 253584213
Owner earnings: 46723867
Return on net tangible assets (%): 18.42538478529024
Buffett classification: The Gruesome
Stock price: 5.13
P/E ratio: 4.5221545346407215
Shares outstanding: 41187631
Book value: 253584213
P/B ratio: 0.8332243735930044
Market cap (USD): 211292547.03
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 10.220423772937757
Free cash flow (dilution-adjusted): 9949774
Buyback yield (%): 8.093044567999877
Retained earnings: -26607515
Receivables turnover: 0.660534619452837
Capitalized R&D asset: 0
FCF margin (%): 247.63642340351058
Revenue growth (%): 208.81403426248949
Rule of 40 score: 456.45045766600003
Financial ratios for MFM — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 253584213
Buffett classification: The Gruesome
Stock price: 5.13
Shares outstanding: 41187631
Book value: 253584213
P/B ratio: 0.8332243735930044
Market cap (USD): 211292547.03
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -26607515
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFM — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 240829331
Buffett classification: The Gruesome
Stock price: 4.86
Shares outstanding: 41187631
Book value: 240829331
P/B ratio: 0.8311773562996777
Market cap (USD): 200171886.66000003
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -39362397
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFM — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 248088365
Buffett classification: The Gruesome
Stock price: 5.22
Shares outstanding: 41187631
Book value: 248088365
P/B ratio: 0.86662441352298
Market cap (USD): 214999433.82
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -32103363
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFM — annual report dated 2025-10-31
Total revenue: 5763632
Net income: 5666000
Capital expenditures: 0
Operating cash flow: 11144287
Net tangible assets: 248088365
Owner earnings: 5666000
Return on net tangible assets (%): 2.283863654790905
Buffett classification: The Gruesome
Stock price: 5.22
P/E ratio: 37.94554073773384
Shares outstanding: 41187631
Book value: 248088365
P/B ratio: 0.86662441352298
Market cap (USD): 214999433.82
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 6.433825060309194
Free cash flow (dilution-adjusted): 11144287
Buyback yield (%): 0
Retained earnings: -32103363
Receivables turnover: 1.007751474437689
Capitalized R&D asset: 0
FCF margin (%): 193.35528361283303
Revenue growth (%): 43.44900841908796
Rule of 40 score: 236.804292031921
Financial ratios for MIRM — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 975000
Buffett classification: The Gruesome
Stock price: 15.95
Shares outstanding: 60981227
Market cap (USD): 972650570.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MIRM — annual report dated 2022-12-31
Total revenue: 77062000
Gross profit: 64688000
Operating income: -131220000
Net income: -135665000
Capital expenditures: 278000
Operating cash flow: -120136000
Depreciation & amortization: 3681000
Net tangible assets: 83083000
Owner earnings: -132262000
Return on net tangible assets (%): -159.19261461430136
Buffett classification: The Gruesome
Stock price: 19.5
Shares outstanding: 60981227
Book value: 142037000
P/B ratio: 8.372001144068095
Market cap (USD): 1189133926.5
Debt to equity: 0.015404436872082627
Current ratio: 2.9387909592300208
Quick ratio: 2.852817129879961
Interest coverage ratio: -8.212028287126854
COGS to revenue (%): 16.057200695543848
R&D to revenue (%): 138.64420855934182
SG&A to revenue (%): 115.57706781552517
Free cash flow (dilution-adjusted): -147421000
Buyback yield (%): 0
Retained earnings: -392824000
Inventory turnover: 2.223539982030548
Receivables turnover: 3.2117195965658083
Capitalized R&D asset: 106842000
ROCI (R&D-adjusted, %): -15.187117581685945
FCF margin (%): -191.30180893306687
Rule of 40 score: -191.30180893306687
Financial ratios for MIRM — annual report dated 2023-12-31
Total revenue: 186374000
Gross profit: 139335000
Operating income: -109154000
Net income: -163415000
Capital expenditures: 109000
Operating cash flow: -70944000
Depreciation & amortization: 10829000
Net tangible assets: -4255000
Owner earnings: -152695000
Buffett classification: The Gruesome
Stock price: 29.52
Shares outstanding: 60981227
Book value: 248670000
P/B ratio: 7.239175698878031
Market cap (USD): 1800165821.04
Debt to equity: 1.2391603329714078
Current ratio: 4.451219792336672
Quick ratio: 4.19494854360011
Interest coverage ratio: -7.226348891095664
COGS to revenue (%): 25.23903548778263
R&D to revenue (%): 55.055426186056
SG&A to revenue (%): 78.27272044383872
Free cash flow (dilution-adjusted): -126076000
Buyback yield (%): 0
Retained earnings: -556239000
Inventory turnover: 2.1082377196127644
Receivables turnover: 2.7420845103578153
Capitalized R&D asset: 174193140
ROCI (R&D-adjusted, %): -10.407084896774261
Rosenberg metric: 0.6986671908051141
FCF margin (%): -67.64677476472039
Revenue growth (%): 141.84941994757466
Rule of 40 score: 74.20264518285427
Financial ratios for MIRM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39
Shares outstanding: 60981227
Market cap (USD): 2378267853
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MIRM — annual report dated 2024-12-31
Total revenue: 336888000
Gross profit: 255245000
Operating income: -87606000
Net income: -87942000
Capital expenditures: 993000
Operating cash flow: 10325000
Depreciation & amortization: 23629000
Net tangible assets: -24179000
Owner earnings: -65306000
Buffett classification: The Gruesome
Stock price: 41.35
Shares outstanding: 60981227
Book value: 225640000
P/B ratio: 11.175207128390356
Market cap (USD): 2521573736.4500003
Debt to equity: 1.4082742421556462
Current ratio: 3.1037921470395333
Quick ratio: 2.9267647035582494
Interest coverage ratio: -6.121584794913004
COGS to revenue (%): 24.234463679323692
R&D to revenue (%): 41.74384365130251
SG&A to revenue (%): 60.026180807864925
Free cash flow (dilution-adjusted): -59112000
Buyback yield (%): 0
Retained earnings: -644181000
Inventory turnover: 3.644288711333304
Receivables turnover: 4.30329816314539
Capitalized R&D asset: 244635890
ROCI (R&D-adjusted, %): -8.071314367711595
Rosenberg metric: 1.1296280053406622
FCF margin (%): -17.54648429151528
Revenue growth (%): 80.7591187612006
Rule of 40 score: 63.21263446968531
Financial ratios for MIRM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.35
Shares outstanding: 60981227
Market cap (USD): 2521573736.4500003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MIRM — quarterly report dated 2025-03-31
Total revenue: 111585000
Gross profit: 88567000
Operating income: -10183000
Net income: -14677000
Capital expenditures: 41000
Operating cash flow: -1961000
Depreciation & amortization: 6052000
Net tangible assets: -10589000
Owner earnings: -8666000
Buffett classification: The Gruesome
Stock price: 45.05
Shares outstanding: 60981227
Book value: 233256000
P/B ratio: 11.777636058022086
Market cap (USD): 2747204276.35
Debt to equity: 1.359690640326508
Current ratio: 3.220157238373688
Quick ratio: 3.044435909293995
Interest coverage ratio: -2.8317575083426028
COGS to revenue (%): 20.628220638974774
R&D to revenue (%): 36.78272169198369
SG&A to revenue (%): 51.714836223506744
Free cash flow (dilution-adjusted): -17805000
Buyback yield (%): 0
Retained earnings: -658858000
Inventory turnover: 1.026764207333393
Receivables turnover: 1.1641384634645078
Capitalized R&D asset: 41044000
ROCI (R&D-adjusted, %): 2.8456725502667934
FCF margin (%): -15.956445758838553
Rule of 40 score: -15.956445758838553
Financial ratios for MIRM — quarterly report dated 2025-06-30
Total revenue: 127785000
Gross profit: 104364000
Operating income: -4989000
Net income: -5861000
Capital expenditures: 126000
Operating cash flow: 12040000
Depreciation & amortization: 6056000
Net tangible assets: 17288000
Owner earnings: 69000
Buffett classification: The Gruesome
Stock price: 50.89
Shares outstanding: 60981227
Book value: 255158000
P/B ratio: 12.162403851848659
Market cap (USD): 3103334642.03
Debt to equity: 1.2498060025552795
Current ratio: 3.1312881571314124
Quick ratio: 2.9728514599850824
Interest coverage ratio: -1.3900808024519364
COGS to revenue (%): 18.328442305434912
R&D to revenue (%): 36.050397151465354
SG&A to revenue (%): 49.52537465273702
Free cash flow (dilution-adjusted): -6554000
Buyback yield (%): 0
Retained earnings: -664719000
Inventory turnover: 1.0209232378710607
Receivables turnover: 1.1960855891272604
Capitalized R&D asset: 73566480
ROCI (R&D-adjusted, %): 1.8394566366391654
Rosenberg metric: 0.3848796413604912
FCF margin (%): -5.128927495402434
Revenue growth (%): 14.51808038714881
Rule of 40 score: 9.389152891746377
Financial ratios for MIRM — quarterly report dated 2025-09-30
Total revenue: 133010000
Gross profit: 107473000
Operating income: 2603000
Net income: 2905000
Capital expenditures: 187000
Operating cash flow: 39681000
Depreciation & amortization: 6062000
Net tangible assets: 60151000
Owner earnings: 8780000
Return on net tangible assets (%): 14.596598560289936
Capex to operating income (%): 7.184018440261237
Buffett classification: The Great
Stock price: 73.31
P/E ratio: 384.72751732960415
Shares outstanding: 60981227
Book value: 292046000
P/B ratio: 15.30763561688912
Market cap (USD): 4470533751.37
Debt to equity: 1.0914855878868397
Current ratio: 3.3086699218628204
Quick ratio: 3.1588747747242127
Effective tax rate (%): -9.912977676882331
Interest coverage ratio: 0.7218524681087077
COGS to revenue (%): 19.199308322682505
R&D to revenue (%): 32.298323434328246
SG&A to revenue (%): 46.54537252838132
Free cash flow (dilution-adjusted): 21367000
Buyback yield (%): 0
Retained earnings: -661814000
Inventory turnover: 1.0631114441530327
Receivables turnover: 1.2415524773177016
Capitalized R&D asset: 87369410
ROCI (R&D-adjusted, %): 0.3097768973024007
Rosenberg metric: 0.06748865782447305
FCF margin (%): 16.064205698819638
Revenue growth (%): 4.088899323081739
Rule of 40 score: 20.153105021901375
Financial ratios for MIRM — annual report dated 2025-12-31
Total revenue: 521312000
Gross profit: 421072000
Operating income: -22136000
Net income: -23363000
Capital expenditures: 954000
Operating cash flow: 55827000
Depreciation & amortization: 24244000
Net tangible assets: 53769000
Owner earnings: -73000
Return on net tangible assets (%): -0.13576596179954992
Buffett classification: The Gruesome
Stock price: 78.99
Shares outstanding: 60981227
Book value: 314690000
P/B ratio: 15.306832504146938
Market cap (USD): 4816907120.73
Debt to equity: 1.0151323524738631
Current ratio: 2.6709750776242838
Quick ratio: 2.5500464045014795
Interest coverage ratio: -1.5383973868927654
COGS to revenue (%): 19.228408323614264
R&D to revenue (%): 35.71335399914063
SG&A to revenue (%): 49.30444724080781
Free cash flow (dilution-adjusted): -16551000
Buyback yield (%): 0
Retained earnings: -667544000
Inventory turnover: 4.027805681681199
Receivables turnover: 4.226968296440444
Capitalized R&D asset: 314261070
ROCI (R&D-adjusted, %): 2.1973665303769603
Rosenberg metric: 1.1791722960961388
FCF margin (%): -3.1748741636486404
Revenue growth (%): 54.74341620954145
Rule of 40 score: 51.56854204589281
Financial ratios for MIRM — quarterly report dated 2025-12-31
Total revenue: 148932000
Gross profit: 120668000
Operating income: -4567000
Net income: -5730000
Capital expenditures: 600000
Operating cash flow: 6067000
Depreciation & amortization: 6074000
Net tangible assets: 53769000
Owner earnings: -256000
Return on net tangible assets (%): -0.4761107701463669
Buffett classification: The Gruesome
Stock price: 78.99
Shares outstanding: 60981227
Book value: 314690000
P/B ratio: 15.306832504146938
Market cap (USD): 4816907120.73
Debt to equity: 1.0151323524738631
Current ratio: 2.6709750776242838
Quick ratio: 2.5500464045014795
Interest coverage ratio: -1.2693162868260144
COGS to revenue (%): 18.97778852093573
R&D to revenue (%): 34.315660838503476
SG&A to revenue (%): 49.773050788279214
Free cash flow (dilution-adjusted): -13559000
Buyback yield (%): 0
Retained earnings: -667544000
Inventory turnover: 1.1356933338690882
Receivables turnover: 1.2075893943079543
Capitalized R&D asset: 95092310
ROCI (R&D-adjusted, %): -0.023402794238084876
Rosenberg metric: 0.30714618249534453
FCF margin (%): -9.104154916337658
Revenue growth (%): 11.970528531689347
Rule of 40 score: 2.866373615351689
Financial ratios for MLMAQ.PA — annual report dated 2021-12-31
Total revenue: 1674818.9545454544
Operating income: 1249597.6363636362
Net income: 1251609.8409090908
Capital expenditures: 881.8522727272727
Operating cash flow: 1325826.7386363638
Depreciation & amortization: 99768.39772727274
Net tangible assets: 8258323.784090909
Owner earnings: 1350496.3863636362
Return on net tangible assets (%): 16.353153759426025
Capex to operating income (%): 0.0705708979486779
Buffett classification: The Great
Stock price: 8.181818181818182
P/E ratio: 37.9825959778019
Shares outstanding: 5810370
Book value: 8258754.102272727
P/B ratio: 5.756242445335495
Market cap (USD): 47539390.90909091
Debt to equity: 0.0056554397655190014
Current ratio: 11.445136240651966
Quick ratio: 11.445136240651966
Effective tax rate (%): 0.7708852234713255
Interest coverage ratio: 1597.5794979079494
COGS to revenue (%): 0
SG&A to revenue (%): 9.573728145432927
Free cash flow (dilution-adjusted): 1324514.5681818184
Buyback yield (%): 0
Retained earnings: 1251609.8409090908
Receivables turnover: 71.36030050098022
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.976510734581554
FCF margin (%): 79.08404455222394
Rule of 40 score: 79.08404455222394
Financial ratios for MLMAQ.PA — annual report dated 2022-12-31
Total revenue: 1820213.7872340425
Operating income: 1426826.329787234
Net income: 1416421.4361702127
Capital expenditures: 0
Operating cash flow: 942678.0319148937
Depreciation & amortization: 92827.87234042553
Net tangible assets: 8093017.191489362
Owner earnings: 1509249.3085106383
Return on net tangible assets (%): 18.648784165413225
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.819148936170213
P/E ratio: 32.07530417436841
Shares outstanding: 5810370
Book value: 8093473.15957447
P/B ratio: 5.613430415903672
Market cap (USD): 45432148.404255316
Debt to equity: 0.003936728754446564
Current ratio: 13.241873505865309
Quick ratio: 13.241873505865309
Effective tax rate (%): 0.6961181671877095
Interest coverage ratio: 2700.4726573511048
COGS to revenue (%): 0
SG&A to revenue (%): 7.402247746254918
Free cash flow (dilution-adjusted): 942678.0319148937
Buyback yield (%): 0
Retained earnings: 1416421.4361702127
Receivables turnover: 38.1781802116199
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.29175261399224
FCF margin (%): 51.78941278910797
Revenue growth (%): 8.681226845085972
Rule of 40 score: 60.470639634193944
Financial ratios for MLMAQ.PA — annual report dated 2023-12-31
Total revenue: 2182640.188888889
Operating income: 1764460.6444444444
Net income: 1769380.6333333333
Capital expenditures: 0
Operating cash flow: 1704391.7555555557
Depreciation & amortization: 91771.63333333333
Net tangible assets: 8890651.333333334
Owner earnings: 1861152.2666666666
Return on net tangible assets (%): 20.93381234835663
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.377777777777778
P/E ratio: 27.51131540021566
Shares outstanding: 5810370
Book value: 8891127.566666668
P/B ratio: 5.474894865884408
Market cap (USD): 48677988.66666667
Debt to equity: 0.002330281865599296
Current ratio: 15.462353330444808
Quick ratio: 15.462353330444808
Effective tax rate (%): 0.5826870002059152
Interest coverage ratio: 1468.6840046242773
COGS to revenue (%): 0
SG&A to revenue (%): 7.4269191526590355
Free cash flow (dilution-adjusted): 1704391.7555555557
Buyback yield (%): 0
Retained earnings: 1769380.6333333333
Receivables turnover: 33.59913018178882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.501058212367134
FCF margin (%): 78.08853535420359
Revenue growth (%): 19.91119967317584
Rule of 40 score: 97.99973502737943
Financial ratios for MLMAQ.PA — annual report dated 2024-12-31
Total revenue: 2144865.5625
Operating income: 1756692.8333333335
Net income: 1770983.9479166667
Capital expenditures: 0
Operating cash flow: 1448993.6354166665
Depreciation & amortization: 84691.28125000001
Net tangible assets: 8613054.666666668
Owner earnings: 1855675.2291666667
Return on net tangible assets (%): 21.544914098227014
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.09375
P/E ratio: 26.554550222107874
Shares outstanding: 5810370
Book value: 8613501.135416668
P/B ratio: 5.459763857710931
Market cap (USD): 47027682.1875
Debt to equity: 0.0008097522684073967
Current ratio: 17.539312847123895
Quick ratio: 17.539312847123895
Effective tax rate (%): 0.5459760454468108
Interest coverage ratio: 12266.694210066922
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 1448993.6354166665
Buyback yield (%): 0
Retained earnings: 1770983.9479166667
Receivables turnover: 17.754658389377717
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.1426500703634
FCF margin (%): 67.55638491989012
Revenue growth (%): -1.7306850016410007
Rule of 40 score: 65.82569991824911